Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Z Stelmasiak

Showing results (71-80 of 76) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 76 results.
Journal of the Neurological Sciences|March 18, 2003
Serum and urine nitrate and nitrite are not reliable indicators of intrathecal nitric oxide production in acute brain injuryK Rejdak, A Petzold, M A Sharpe, et al.
European Journal of Neurology|November 23, 2006
Increased urinary excretion of nitric oxide metabolites in longitudinally monitored migraine patientsK Rejdak, M Empl, N J Giffin, et al.
Neurology|October 27, 2004
CSF nitric oxide metabolites are associated with activity and progression of multiple sclerosisK Rejdak, M J Eikelenboom, A Petzold, et al.
European Journal of Neurology|March 3, 2011
A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex(®) ), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosisA Novotna, J Mares, S Ratcliffe, et al.
Cerebrovascular Diseases (Basel, Switzerland)|April 11, 2003
A double-blind randomised placebo-controlled evaluation of three doses of botulinum toxin type A (Dysport) in the treatment of spastic equinovarus deformity after strokeS J Pittock, A P Moore, O Hardiman, et al.
Journal of Neurology|December 14, 2004
Escalating immunotherapy of multiple sclerosis--new aspects and practical applicationP Rieckmann, K V Toyka, C Bassetti, et al.
Pageof 8

Showing results (71-80 of 76) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 76 results.
Journal of the Neurological Sciences|March 18, 2003
Serum and urine nitrate and nitrite are not reliable indicators of intrathecal nitric oxide production in acute brain injuryK Rejdak, A Petzold, M A Sharpe, et al.
European Journal of Neurology|November 23, 2006
Increased urinary excretion of nitric oxide metabolites in longitudinally monitored migraine patientsK Rejdak, M Empl, N J Giffin, et al.
Neurology|October 27, 2004
CSF nitric oxide metabolites are associated with activity and progression of multiple sclerosisK Rejdak, M J Eikelenboom, A Petzold, et al.
European Journal of Neurology|March 3, 2011
A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex(®) ), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosisA Novotna, J Mares, S Ratcliffe, et al.
Cerebrovascular Diseases (Basel, Switzerland)|April 11, 2003
A double-blind randomised placebo-controlled evaluation of three doses of botulinum toxin type A (Dysport) in the treatment of spastic equinovarus deformity after strokeS J Pittock, A P Moore, O Hardiman, et al.
Journal of Neurology|December 14, 2004
Escalating immunotherapy of multiple sclerosis--new aspects and practical applicationP Rieckmann, K V Toyka, C Bassetti, et al.
Pageof 8